Rangarajan, Sunad
Locy, Morgan L.
Luckhardt, Tracy R.
Thannickal, Victor J.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (HL114470, HL105346)
National Institute on Aging (AG046210)
National Institute of General Medical Sciences (GM008361)
Article History
First Online: 4 January 2016
Compliance with Ethical Standards
:
: No specific sources of funding were used to support the writing of this manuscript.
: Tracy Luckhardt participated in an Advisory Board for Intermune Inc. (the manufacturer of pirfenidone) in June 2014 and received an honorarium and travel expenses. Sunad Rangarajan, Morgan Locy and Victor Thannickal have no conflicts of interest to report.
Free to read: This content has been made available to all.